136 related articles for article (PubMed ID: 3939152)
1. A benefit-cost analysis of a childhood varicella vaccination programme.
Preblud SR; Orenstein WA; Koplan JP; Bart KJ; Hinman AR
Postgrad Med J; 1985; 61 Suppl 4():17-22. PubMed ID: 3939152
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
3. Varicella: complications and costs.
Preblud SR
Pediatrics; 1986 Oct; 78(4 Pt 2):728-35. PubMed ID: 3093966
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
5. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
[TBL] [Abstract][Full Text] [Related]
6. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
7. Childhood vaccination against chickenpox: an analysis of benefits and costs.
Huse DM; Meissner HC; Lacey MJ; Oster G
J Pediatr; 1994 Jun; 124(6):869-74. PubMed ID: 8201469
[TBL] [Abstract][Full Text] [Related]
8. The case against universal varicella vaccination.
Goldman GS
Int J Toxicol; 2006; 25(5):313-7. PubMed ID: 16940003
[TBL] [Abstract][Full Text] [Related]
9. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
Goldman GS
Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
[TBL] [Abstract][Full Text] [Related]
10. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit analysis of routine mumps and rubella vaccination for Israeli infants.
Berger SA; Ginsberg GM; Slater PE
Isr J Med Sci; 1990 Feb; 26(2):74-80. PubMed ID: 2108102
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic considerations of vaccination against varicella.
Strassels SA; Sullivan SD
Pharmacotherapy; 1997; 17(1):133-9. PubMed ID: 9017774
[TBL] [Abstract][Full Text] [Related]
13. Perspective on live varicella vaccine.
Gershon AA; Katz SL
J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.
Lieu TA; Finkler LJ; Sorel ME; Black SB; Shinefield HR
Pediatrics; 1995 May; 95(5):632-8. PubMed ID: 7724297
[TBL] [Abstract][Full Text] [Related]
15. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
Tseng HF; Tan HF; Chang CK
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of varicella vaccination programs: an update of the literature.
Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
[TBL] [Abstract][Full Text] [Related]
19. Measles control in developing and developed countries: the case for a two-dose policy.
Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
[TBL] [Abstract][Full Text] [Related]
20. Varicella zoster vaccines.
Creed R; Satyaprakash A; Ravanfar P
Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
